Literature DB >> 102693

A new B cell differentiation antigen (BDA) on normal and leukemic human B lymphocytes that is distinct from known DR (Ia-like) antigens.

C M Balch, P A Dougherty, L B Vogler, E W Ades, S Ferrone.   

Abstract

A newly defined human B cell differentiation antigen, designated as BDA, has been defined and partially characterized. BDA is expressed on normal human B cells and lymphocytic leukemia cells at all stages of known differentiation (pre-B cells to plasma cells). It is distinct from DR (Ia-like) determinants and other known B cell surface constituents.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 102693

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  Pre-B cells; normal and abnormal development.

Authors:  M D Cooper
Journal:  J Clin Immunol       Date:  1981-04       Impact factor: 8.317

2.  Immunologic diagnosis and monitoring of human acute leukemias: a review.

Authors:  M Maheu; M A Baker; J A Falk; R N Taub
Journal:  Am J Pathol       Date:  1981-04       Impact factor: 4.307

3.  Differentiation between benign and malignant monoclonal gammopathy by the presence of the J chain.

Authors:  E J Bast; B Van Camp; S E Boom; F C Jaspers; R E Ballieux
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

4.  A human B lymphocyte antigen (P-76) shared by B-cell chronic lymphocytic leukemia cells and hairy cell leukemia cells.

Authors:  Y Kanakura; T Machii; Y Kurata; T Tamaki; T Yonezawa; S Tarui; T Kitani
Journal:  Blut       Date:  1983-05

5.  Isolation and immunological characterization of a major surface glycoprotein (gp54) preferentially expressed on certain human B cells.

Authors:  C Y Wang; S M Fu; H G Kunkel
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

6.  Ultrastructural studies of human lymphoid cells. mu and J chain expression as a function of B cell differentiation.

Authors:  I Hajdu; Z Moldoveanu; M D Cooper; J Mestecky
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.